85%Confidence
0Views
FDASource
2026-04-10Date
Summary
Strides Pharma's Class II recall for Children's Ibuprofen due to foreign particles indicates serious contamination problems that could trigger consumer distrust and regulatory penalties. This may impact Taro Pharmaceuticals' brand reputation and sales in the pediatric OTC pain relief market, favoring competitors like Johnson & Johnson.
Actionable: Recommend switching to alternative pediatric ibuprofen brands like Advil or Motrin until quality is assured.
AI Confidence: 85%
Data Points
firmSTRIDES PHARMA INC
classificationClass II
statusOngoing
distributionU.S.A. Nationwide
productChildren's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now